India Point-of-Care Molecular Diagnostics Market (2025-2030)
The India Point-of-Care Molecular Diagnostics Market was valued at $57.7 Million in 2025 and projected to reach to $113.2 Million by 2030, representing a compound annual growth rate of 14.4%. India's point-of-care molecular diagnostics market is positioned for substantial growth, expanding from USD 57.7 million in 2025 to USD 113.2 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Point-of-Care Molecular Diagnostics Market Trends and Insights
- India's market growth significantly outpaces the global average of 10.5% CAGR, driven by rising infectious disease prevalence, expanding healthcare infrastructure, and increasing adoption of rapid diagnostic solutions across rural and urban settings.
- India's healthcare sector is increasingly prioritizing decentralized testing capabilities to improve patient outcomes and reduce diagnostic turnaround times. The acceleration in India's point-of-care molecular diagnostics adoption reflects growing government initiatives, including the National Health Mission and diagnostic infrastructure investments.
- India's market is benefiting from heightened awareness of infectious diseases, particularly post-pandemic, and the need for accessible testing in resource-limited settings.
- India's pharmaceutical and diagnostics companies are investing heavily in developing cost-effective molecular solutions tailored to local healthcare needs, positioning the country as a key growth engine within the Asia Pacific region..
Key Market Statistics
- CAGR (2025-2030) 14.4% CAGR
- Market Size, 2025 ~USD 57.7 Million
- Forecast, 2030 ~USD 113.2 Million
- Country India
India Point-of-Care Molecular Diagnostics Market Overview
Rapid Market Expansion :
India's point-of-care molecular diagnostics market is growing at 14.4% CAGR, significantly outpacing the global average of 10.5%, reflecting strong domestic demand and healthcare modernization initiatives.
Rural Healthcare Penetration :
Increasing adoption of rapid diagnostic solutions across rural India is driving market growth, as point-of-care testing addresses accessibility challenges in underserved regions with limited laboratory infrastructure.
Infectious Disease Burden :
Rising prevalence of infectious diseases including tuberculosis, dengue, and COVID-19 variants is fueling demand for rapid, accurate molecular diagnostics in India's healthcare system.
Healthcare Infrastructure Investment :
Government initiatives like Ayushman Bharat and expanding primary health centers are creating favorable conditions for point-of-care molecular diagnostic adoption across India's healthcare ecosystem.
India Point-of-Care Molecular Diagnostics Market Dynamics
- This trajectory reflects India's commitment to strengthening diagnostic capabilities and improving healthcare accessibility across urban and rural populations.
- The market benefits from increasing disease surveillance requirements, growing awareness of early detection benefits, and government support for diagnostic infrastructure development. Key growth drivers include the rising burden of infectious diseases, expanding middle-class healthcare spending, and technological advancements making diagnostics more affordable and user-friendly.
- Strategic partnerships between diagnostic manufacturers and healthcare providers, coupled with regulatory support for point-of-care testing, are expected to accelerate market penetration.
- India's position as a global healthcare hub further supports innovation and competitive pricing in the molecular diagnostics segment..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- India's point-of-care molecular diagnostics market is projected to nearly double from USD 57.7M (2025) to USD 113.2M (2030), growing at 14.4% CAGR.
- India's market growth rate exceeds the global CAGR of 10.5%, reflecting strong regional demand and healthcare modernization initiatives.
- India's expanding rural healthcare infrastructure and government diagnostic programs are key drivers accelerating adoption of point-of-care molecular testing.
- India's competitive landscape features both multinational diagnostics companies and domestic players developing affordable, locally-optimized molecular diagnostic solutions.
Point-of-Care Molecular Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SEPSIS (Disease Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 10.5% from 2025 to 2030 |
| Largest Segment | RT-PCR (Technology) |
| Market Size Base Year (Billions) | ~USD 4.3 (2025) |
| Revenue Forecast (Billions) | ~USD 7.09 (2030) |
| Segments Covered | Product & Service, Technology, Sample Type, Application, End User, Disease Type |
India Point-of-Care Molecular Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Assays & Kits
- Instruments & Analyzers
- Software & Services
By Technology
- Inaat
- Other Technologies
- Rt-Pcr
By Sample Type
- Blood Samples
- Other Sample Types
- Urine Samples
By Application
- Cancer
- Gastrointestinal Disorders
- Hepatitis
- Hospital-Acquired Infections
- Other Applications
- Respiratory Diseases
- Sexually Transmitted Diseases
By End User
- Hospitals
- Other End Users
- Physicians' Offices/Clinics
- Research Institutes
By Disease Type
- Gastroenteritis
- Meningoencephalitis
- Other Diseases
- Sepsis
INDIA: POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS | 34.4 | 37.9 | 42.1 | 47.2 | 53.6 | 61.4 | 70.9 | 82.8 | 14.5 |
| OTHER END USERS | 10.2 | 10.9 | 11.8 | 12.8 | 14.1 | 15.7 | 17.7 | 20 | 11.3 |
| PHYSICIANS' OFFICES/CLINICS | 30.6 | 33.4 | 36.7 | 40.7 | 45.6 | 51.6 | 58.9 | 67.9 | 13.1 |
| RESEARCH INSTITUTES | 3 | 3.2 | 3.5 | 3.7 | 4.1 | 4.5 | 5 | 5.6 | 10.2 |
| TOTAL | 78.2 | 85.4 | 94 | 104.5 | 117.4 | 133.2 | 152.5 | 176.3 | 13.4 |
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need India-specific market data to assess market opportunity, benchmark against competitors, and develop localized product strategies for the rapidly expanding point-of-care diagnostics segment.
- Healthcare Investors & PE Firms : Investment professionals require detailed India market analysis to evaluate portfolio opportunities, assess growth potential, and make informed funding decisions in the high-growth diagnostics sector.
- Hospital & Clinic Networks : Healthcare providers need market insights to understand diagnostic technology trends, evaluate supplier options, and plan capital investments in point-of-care testing infrastructure for their facilities.
- Government & Policy Makers : Healthcare administrators and policymakers require market data to inform healthcare infrastructure planning, diagnostic accessibility initiatives, and regulatory frameworks supporting point-of-care testing adoption.
- Distributors & Channel Partners : Distribution and logistics partners need India market intelligence to identify growth opportunities, optimize inventory planning, and develop effective go-to-market strategies for diagnostic products.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India (USD 57.7M in 2025) with verified 14.4% CAGR projections through 2030, enabling accurate business planning and investment decisions specific to the Indian market.
- Competitive Landscape Intelligence : Understand India-specific competitive dynamics, market consolidation trends, and key player strategies to identify partnership opportunities and market positioning advantages in this high-growth segment.
- Regional Growth Drivers Analysis : Access detailed insights into India's unique growth catalysts including rural healthcare expansion, infectious disease prevalence patterns, and government healthcare initiatives shaping market demand.
- Investment & Expansion Strategy : Leverage India-focused market data to develop targeted go-to-market strategies, identify high-potential geographic segments, and optimize resource allocation for market entry or expansion.
- Regulatory & Reimbursement Insights : Gain understanding of India's regulatory environment, reimbursement policies, and healthcare infrastructure developments critical for product commercialization and market success in this jurisdiction.
Frequently asked questions
What is the current market size of point-of-care molecular diagnostics in India?
India's point-of-care molecular diagnostics market was valued at USD 57.7 million in 2025 and is expected to grow to USD 113.2 million by 2030.
What is the projected growth rate for India's point-of-care molecular diagnostics market?
India's market is projected to grow at a compound annual growth rate (CAGR) of 14.4% from 2025 to 2030, outpacing the global average.
What factors are driving growth in India's point-of-care molecular diagnostics market?
Key drivers include rising infectious disease prevalence, government healthcare initiatives, expanding rural healthcare infrastructure, and increasing demand for rapid, decentralized diagnostic solutions in India.
How does India's market growth compare to global trends?
India's 14.4% CAGR significantly exceeds the global CAGR of 10.5%, positioning India as a high-growth market within the Asia Pacific region.
Which segments are most prominent in India's point-of-care molecular diagnostics market?
India's market is driven by infectious disease diagnostics, particularly respiratory and bloodborne pathogen testing, alongside growing demand for rapid molecular solutions in primary care and remote settings.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the point-of-care molecular diagnostics market. Exhaustive secondary research was done to collect information on the point-of-care molecular diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the point-of-care molecular diagnostics market.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold-standard & silver-standard websites; regulatory bodies; and databases like D&B Hoovers, Bloomberg Business, and Factiva, were referred to identify and collect information for this study.
Primary Research
In the primary research process, primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
Breakdown of Primaries
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both bottom-up and top-down approaches were used to estimate and validate the point-of-care molecular diagnostics market’s total size. These methods were also used extensively to estimate the size of various subsegments in tkehe mart. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenues generated by leading players operating in the point-of-care molecular diagnostics market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Point-of-care molecular diagnostics includes various portable point-of-care devices and assays used by healthcare professionals to detect and diagnose diseases in humans using different techniques to identify and analyze nucleic acids or proteins at the molecular level.
Stakeholders
- Manufacturers and distributors of point-of-care molecular diagnostics products
- Physicians’ offices
- Hospitals and clinics
- Research institutes
- Point-of-care molecular diagnostics service providers
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, segment, and forecast the point-of-care molecular diagnostics market by product & service, technology, sample type, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as acquisitions, expansions, product launches & approvals, and other developments in the point-of-care molecular diagnostics market
- To benchmark players within the point-of-care molecular diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full Point-of-Care Molecular Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Point-of-Care Molecular Diagnostics Market.
- US Point-of-Care Molecular Diagnostics Market
- Canada Point-of-Care Molecular Diagnostics Market
- Germany Point-of-Care Molecular Diagnostics Market
- UK Point-of-Care Molecular Diagnostics Market
- France Point-of-Care Molecular Diagnostics Market
- Italy Point-of-Care Molecular Diagnostics Market
- Spain Point-of-Care Molecular Diagnostics Market
- China Point-of-Care Molecular Diagnostics Market
- Japan Point-of-Care Molecular Diagnostics Market
- Brazil Point-of-Care Molecular Diagnostics Market
- Mexico Point-of-Care Molecular Diagnostics Market
- Rest Of Europe Point-of-Care Molecular Diagnostics Market
- Rest Of Asia Pacific Point-of-Care Molecular Diagnostics Market
- Rest Of Latin America Point-of-Care Molecular Diagnostics Market
- Ksa Point-of-Care Molecular Diagnostics Market
- UAE Point-of-Care Molecular Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
